Recurrent Glioblastoma Multiforme (GBM) Treatment Report

By www.marketgrowthrate.com

 Request Sample Report

Report Details

Report Name

Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Insights, Forecast To 2028 Story

Pages

92

Price

$ 4900

 Request Sample Report

Features

Recurrent Glioblastoma Multiforme (GBM) Treatment Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

 Request Sample Report

Companies Covered

              Astrazeneca
Roche
GlaxoSmithKline
Merck
Pfizer
AngioChem
Vascular Biogeneics
Request Sample Report